Novo Nordisk A S (NVO) Price Targets From Analysts
Use the tables below to see what analysts covering Novo Nordisk A S think about its future price and what recommendations they have for investors and traders.
|Number of Analysts||Highest Target Price||Lowest Target Price||Average Target Price||Current Price||Upside Potential|
NVO Broker Recommendations Summary
|Average Broker Rating||Strong Buy||Buy||Hold||Sell||Strong Sell||Analysts Issuing Recs|
Use the points listed below to better contextualize what this analyst price target and recommendations data data means for investors.
- The number of analysts covering the stock of NVO is higher than 94.8% of all US stocks.
- Novo Nordisk A S's upside potential (average analyst target price relative to current price) is higher than 7.12% of Pharmaceutical Products stocks.
- The percent of analysts bearish on the stock of NVO is lower than 10.64% of Pharmaceutical Products stocks.
- NVO has a greater average analyst price target than 85.38% of Pharmaceutical Products stocks.
- NVO has a higher percentage of analysts bullish on the stock than 15.43% of Pharmaceutical Products stocks.
- Novo Nordisk A S's variance in analysts' estimates is less than 33.11% of all US stocks.
- NVO has a less change in bullishness amongst analysts than nearly 100% of all US stocks.
Is NVO a Buy, Hold or Sell? See the POWR Ratings now!